M&A Deal Summary |
|
|---|---|
| Date | 2015-10-14 |
| Target | YES Pharmaceutical Development Services |
| Sector | Healthcare Services |
| Buyer(s) | PharmaLex |
| Sellers(s) | AUCTUS Capital Partners |
| Deal Type | Merger |
SEARCH BY
PharmaLex is a provider of solutions for drug development, regulatory affairs, and pharmacovigilance. The company features a multidisciplinary team from more than 40 nationalities with knowledge that spans the whole spectrum of life sciences, including biology, biochemistry, pharmacology, engineering, food chemistry, medicine, nutritional science, pharmacy science, toxicology, and veterinary medicine. PharmaLex is based in Frankfurt, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 13 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Merger M&A Deals | 1 of 3 |
| Country: Germany M&A | 1 of 2 |
| Year: 2015 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-23 |
Lindeq AS
Oslo, Norway Lindeq AS is a medical consultancy specialized in drug safety and pharmacovigilance, cosmetovigilance, quality management, and medical device vigilance. Lindeq AS services offered stretch cover the entire product lifecycle - pre and post product launch. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 1.0B EUR |
| Size | Middle-Market |
| Type | Sector Agnostic |
AUCTUS Capital Partners AG targets small-cap and mid-market opportunities in German-speaking countries (primarily Germany, Switzerland and Austria). The Firm focuses on 'sustainable' companies operating in fragmented sectors with strong market positions and growth potential. AUCUTS generally looks to invest in companies valued between €10 and €100 million with revenues of €10 to €200 million. Areas of interest include healthcare, automotive, fine chemicals/pharma, IT/software, education, and business services. The Firm will consider a variety of transaction types including buy-and-build, MBOs, MBIs, and spin-offs/carve-outs. AUCTUS Capital Partners AG was formed in 2001 and is based in Munich.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 19 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Merger M&A Deals | 1 of 1 |
| Country: Germany M&A | 11 of 17 |
| Year: 2015 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-10-14 |
PharmaLex
Frankfurt, Germany PharmaLex is a provider of solutions for drug development, regulatory affairs, and pharmacovigilance. The company features a multidisciplinary team from more than 40 nationalities with knowledge that spans the whole spectrum of life sciences, including biology, biochemistry, pharmacology, engineering, food chemistry, medicine, nutritional science, pharmacy science, toxicology, and veterinary medicine. PharmaLex is based in Frankfurt, Germany. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-11 |
IU Group
Munich, Germany IU Group is a provider of private education and personnel development. IU Group offers academic state-approved study programs, certified trainings, and innovative continuous education programs for experts and managers of all industries. IU Group is an e-learning provider in Germany offering a multitude of courses, distance learning modules, company-specific solutions, and services in the field of digital learning. IU Group was founded in 2007 and is based in Munich, Germany. |
Sell | €107M |
